[Cytosine arabinoside as a polyvalent drug in the treatment of acute non-lymphoid leukemias].
D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001682:Biological Availability; D002454:Cell Differentiation / Q000187:drug effects; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism; D008214:Lymphocytes / Q000187:drug effects
D003561:Cytarabine
El arabinósido de citosina como droga polivalente en el tratamiento de las leucemias agudas no linfoides.